239 related articles for article (PubMed ID: 1941621)
1. A new type of vasodilator, HA1077, an isoquinoline derivative, inhibits proliferation of bovine vascular smooth muscle cells in culture.
Shirotani M; Yui Y; Hattori R; Kawai C
J Pharmacol Exp Ther; 1991 Nov; 259(2):738-44. PubMed ID: 1941621
[TBL] [Abstract][Full Text] [Related]
2. HA-1077 suppress both proliferation of vascular smooth muscle cells and c-fos mRNA induction.
Sase K; Yui Y; Hattori R; Shirotani M; Kawai C; Sasayama S
Jpn Circ J; 1992 Dec; 56(12):1229-33. PubMed ID: 1479648
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of myosin light chain phosphorylation in cultured smooth muscle cells by HA1077, a new type of vasodilator.
Sasaki Y; Sasaki Y
Biochem Biophys Res Commun; 1990 Sep; 171(3):1182-7. PubMed ID: 2222437
[TBL] [Abstract][Full Text] [Related]
4. Effects of isoquinoline derivatives, HA1077 and H-7, on cytosolic Ca2+ level and contraction in vascular smooth muscle.
Takizawa S; Hori M; Ozaki H; Karaki H
Eur J Pharmacol; 1993 Dec; 250(3):431-7. PubMed ID: 8112403
[TBL] [Abstract][Full Text] [Related]
5. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
7. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase.
Asano T; Suzuki T; Tsuchiya M; Satoh S; Ikegaki I; Shibuya M; Suzuki Y; Hidaka H
Br J Pharmacol; 1989 Dec; 98(4):1091-100. PubMed ID: 2611484
[TBL] [Abstract][Full Text] [Related]
8. Concanavalin A- and fetal-calf-serum-induced rounding and myosin light chain phosphorylation in cultured smooth muscle cells.
Sasaki Y; Iwata K; Sasaki Y
J Cell Physiol; 1990 Aug; 144(2):183-9. PubMed ID: 2116423
[TBL] [Abstract][Full Text] [Related]
9. Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle.
Seto M; Sasaki Y; Hidaka H; Sasaki Y
Eur J Pharmacol; 1991 Mar; 195(2):267-72. PubMed ID: 1874276
[TBL] [Abstract][Full Text] [Related]
10. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells.
Wang DJ; Huang NN; Heppel LA
J Cell Physiol; 1992 Nov; 153(2):221-33. PubMed ID: 1358898
[TBL] [Abstract][Full Text] [Related]
11. U-61,431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells.
Shirotani M; Yui Y; Hattori R; Kawai C
Prostaglandins; 1991 Feb; 41(2):97-110. PubMed ID: 1708156
[TBL] [Abstract][Full Text] [Related]
12. A neutrophil derived factor(s) stimulates [3H]thymidine incorporation by vascular smooth muscle cells in vitro.
Cole CW; Makhoul RG; McCann RL; O'Malley MK; Hagen PO
Clin Invest Med; 1988 Feb; 11(1):62-7. PubMed ID: 3365883
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.
del Rio M; Sunkel C; Larcher F; Ortega MP
Br J Pharmacol; 1997 Apr; 120(7):1360-6. PubMed ID: 9105713
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle-dependent inhibition of DNA synthesis by prostaglandin I2 in cultured rabbit aortic smooth muscle cells.
Morisaki N; Kanzaki T; Motoyama N; Saito Y; Yoshida S
Atherosclerosis; 1988 Jun; 71(2-3):165-71. PubMed ID: 3041980
[TBL] [Abstract][Full Text] [Related]
16. Effect of elastase on aortic smooth muscle cell proliferation.
Kawaguchi H; Sano H; Kudo T; Yasuda H
Jpn Heart J; 1991 Jan; 32(1):131-8. PubMed ID: 2038118
[TBL] [Abstract][Full Text] [Related]
17. Synchronization of cultured vascular smooth muscle cells following reversal of quiescence induced by treatment with the antioxidant N-acetylcysteine.
Lee JS; Kypreos KE; Sonenshein GE
Exp Cell Res; 1998 Mar; 239(2):447-53. PubMed ID: 9521863
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation.
Reil TD; Kashyap VS; Sarkar R; Freishlag J; Gelabert HA
J Surg Res; 2000 Jul; 92(1):108-13. PubMed ID: 10864490
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions.
Little PJ; Osman N; de Dios ST; Cemerlang N; Ballinger M; Nigro J
Cardiovasc Diabetol; 2007 Oct; 6():33. PubMed ID: 17963526
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative effects of benidipine hydrochloride in porcine cultured vascular smooth muscle cells and in rats subjected to balloon catheter-induced endothelial denudation.
Ide S; Kondoh M; Satoh H; Karasawa A
Biol Pharm Bull; 1994 May; 17(5):627-31. PubMed ID: 7920421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
